OPKO HEALTH INC. - COMMON STOCK

OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test

08 дек 2021 08:00:02 Источник Nasdaq GlobeNewswire

OPKO Health Announces the Passing of Director Dr. Richard Lerner

06 дек 2021 08:00:02 Источник Nasdaq GlobeNewswire

OPKO Health Announces Participation in Piper Sandler 33rd Annual Virtual Healthcare Conference

29 ноя 2021 08:00:01 Источник Nasdaq GlobeNewswire

OPKO Health Reports 2021 Third Quarter Business Highlights and Financial Results

28 окт 2021 16:15:01 Источник Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2021 Financial Results on October 28, 2021

25 окт 2021 10:57:14 Источник Nasdaq GlobeNewswire

Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency

24 сен 2021 16:24:07 Источник Nasdaq GlobeNewswire

LeaderMed Group and OPKO Health Form Joint Venture to Develop and Commercialize Oxyntomodulin and Factor VIIa-CTP in China and Other Asian Territories

14 сен 2021 08:00:01 Источник Nasdaq GlobeNewswire

OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients

30 авг 2021 16:17:19 Источник Nasdaq GlobeNewswire

OPKO Health to Participate in Two Upcoming Investment Conferences

30 авг 2021 09:04:49 Источник Nasdaq GlobeNewswire

OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results

29 июл 2021 16:05:01 Источник Nasdaq GlobeNewswire

OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021

20 июл 2021 08:00:02 Источник Nasdaq GlobeNewswire

OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

12 июл 2021 08:00:01 Источник Nasdaq GlobeNewswire

OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference

08 июл 2021 16:05:00 Источник Nasdaq GlobeNewswire

OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

22 июн 2021 08:00:00 Источник Nasdaq GlobeNewswire

OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

21 июн 2021 08:03:07 Источник Nasdaq GlobeNewswire

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland

17 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire

OPKO Health to Participate in the Jefferies Virtual Healthcare Conference

27 май 2021 08:30:01 Источник Nasdaq GlobeNewswire

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

24 май 2021 07:30:00 Источник Nasdaq GlobeNewswire

OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders

07 май 2021 13:33:56 Источник Nasdaq GlobeNewswire

OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021

22 апр 2021 08:00:01 Источник Nasdaq GlobeNewswire